跳至主要内容
临床试验/NCT01902602
NCT01902602终止不适用

Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia

Herrmann Apparatebau GmbH1 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2013年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
19
试验地点
1
主要终点
Change of blood pressure

研究概览

简要总结

The objective of this clinical study is to evaluate the influence of the Great autohemotherapy with oxygen-ozone (hyperbaric ozone therapy ) to describe the cardiovascular system in patients with resistant hypertension. The primary endpoint is the change in mean blood pressure after 10 treatments .

In addition, data are collected on the immune system as well as for food and sleep quality.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Resistant Hypertension > 140 / > 90mmHg
  • Inclusion age : 45 +
  • Regular monitoring of blood levels considered
  • pre-medication to lower blood pressure for at least 3 weeks before the preliminary investigation consistent
  • Men and Women

排除标准

  • derailed diabetes
  • renal impairment , renal creatinine clear <50 ml
  • Non - austherapierte cancer / tumor patients
  • Non - adjusted thyroid dysfunction
  • LVEF <limit ( " 35% " )
  • Peripheral AVK ( ABI - measurement ) > Stage II
  • regurgitation > Stage I
  • abdominal aneurysm
  • infections
  • acute febrile infections with temperature > 38.5 ° C
  • COPD and asthma to stage III
  • dyspnea NYHA > Stage III
  • z.n. Stroke shorter than 12 weeks
  • Acute liver failure
  • Acute Apoplexy
  • Severe poisoning
  • drug addiction
  • hyperthyroidism
  • Hypotension
  • hypocalcemia
  • hypoglycemia
  • ozone allergy
  • pregnancy
  • clotting problems ( hemophilia )
  • pre-existing condition with hemoglobin < 9mg/dl
  • Fresh myocardial infarction
  • Internal bleeding
  • thrombocytopenia
  • Acute alcohol
  • Citrus allergy when using sodium citrate

结局指标

主要结局

Change of blood pressure

时间窗: 3 months

Primary endpoint is, that there is a changing of the middle blood pressure after 10 treatments. The blood pressure will get messured at all patients which get treated with oxygen-ozone. The aim is reached, if there is a reduction of the middle blood pressure after 10 treatments by 10 mmHg compared to the blood pressure by the patients at the baseline at beginning.

次要结局

  • Change of life and Sleeping quality(3 months)
  • Change of blood count, liver and nephrew values(3 months)
  • Change of liver and nephrew values(3 months)
  • Change of pulse(3 months)

研究者

发起方
Herrmann Apparatebau GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验